Cargando…

Target Score—A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness

Esophageal cancer (EC) is a life-threatening disease, demanding the discovery of new biomarkers and molecular targets for precision oncology. Aberrantly glycosylated proteins hold tremendous potential towards this objective. In the current study, a series of esophageal squamous cell carcinomas (ESCC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cotton, Sofia, Ferreira, Dylan, Soares, Janine, Peixoto, Andreia, Relvas-Santos, Marta, Azevedo, Rita, Piairo, Paulina, Diéguez, Lorena, Palmeira, Carlos, Lima, Luís, Silva, André M. N., Lara Santos, Lúcio, Ferreira, José Alexandre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915893/ https://www.ncbi.nlm.nih.gov/pubmed/33562270 http://dx.doi.org/10.3390/ijms22041664

Ejemplares similares

Nucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer Cells
por: Fernandes, Elisabete, et al.
Publicado: (2020)

The Role of Sialyl-Tn in Cancer
por: Munkley, Jennifer
Publicado: (2016)

The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL
por: Beatson, Richard, et al.
Publicado: (2015)

Phenotypic Analysis of Urothelial Exfoliated Cells in Bladder Cancer via Microfluidic Immunoassays: Sialyl-Tn as a Novel Biomarker in Liquid Biopsies
por: Carvalho, Sandra, et al.
Publicado: (2020)

Protein Glycosylation and Tumor Microenvironment Alterations Driving Cancer Hallmarks
por: Peixoto, Andreia, et al.
Publicado: (2019)

Chemical and Enzymatic Synthesis of Sialylated Glycoforms of Human Erythropoietin
por: Hessefort, Hendrik, et al.
Publicado: (2021)

Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients
por: Carneiro, Adriana, et al.
Publicado: (2022)

Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion
por: Gaiteiro, Cristiana, et al.
Publicado: (2022)

Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer
por: Peixoto, Andreia, et al.
Publicado: (2021)

The (Sialyl) Tn antigen: Contributions to immunosuppression in gastrointestinal cancers
por: Rajesh, Christabelle, et al.
Publicado: (2023)

Challenges in Antibody Development against Tn and Sialyl-Tn Antigens
por: Loureiro, Liliana R., et al.
Publicado: (2015)

Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy
por: Lima, L, et al.
Publicado: (2013)

CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications
por: Azevedo, Rita, et al.
Publicado: (2018)

Increased sialylation of site specific O-glycoforms of hemopexin in liver disease
por: Sanda, Miloslav, et al.
Publicado: (2016)

Sialyl Tn as a prognostic marker in epithelial ovarian cancer.
por: Kobayashi, H., et al.
Publicado: (1992)

Sialyl-Tn in Cancer: (How) Did We Miss the Target?
por: Julien, Sylvain, et al.
Publicado: (2012)

Glycoproteogenomics: Setting the Course for Next-generation Cancer Neoantigen Discovery for Cancer Vaccines
por: Ferreira, José Alexandre, et al.
Publicado: (2021)

Targeted O‐glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced‐stage bladder tumours
por: Cotton, Sofia, et al.
Publicado: (2017)

Sialyl-Tn Antigen-Imprinted Dual Fluorescent Core–Shell Nanoparticles for Ratiometric Sialyl-Tn Antigen Detection and Dual-Color Labeling of Cancer Cells
por: Jiang, Shan, et al.
Publicado: (2022)

Demethylation of the Cosmc Promoter Alleviates the Progression of Breast Cancer Through Downregulation of the Tn and Sialyl-Tn Antigens
por: Xu, Feng, et al.
Publicado: (2020)

A Quantitative Microtiter Assay for Sialylated Glycoform Analyses Using Lectin Complexes
por: Srinivasan, Karunya, et al.
Publicado: (2015)

Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio
por: Katorcha, Elizaveta, et al.
Publicado: (2015)

Expression of sialyl-Tn in gastric cancer: correlation with known prognostic factors.
por: Miles, D. W., et al.
Publicado: (1995)

P53 and Cancer-Associated Sialylated Glycans Are Surrogate Markers of Cancerization of the Bladder Associated with Schistosoma haematobium Infection
por: Santos, Júlio, et al.
Publicado: (2014)

Demethylation of the Cosmc Promoter Alleviates the Progression of Breast Cancer Through Downregulation of the Tn and Sialyl-Tn Antigens [Retraction]
Publicado: (2022)

Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology
por: Fernandes, Elisabete, et al.
Publicado: (2020)

Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids
por: Loureiro, Liliana R., et al.
Publicado: (2018)

Polymeric nanoparticles targeting Sialyl-Tn in gastric cancer: A live tracking under flow conditions
por: Diniz, Francisca, et al.
Publicado: (2022)

Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma
por: Eavarone, David A., et al.
Publicado: (2018)

Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer.
por: Miles, D. W., et al.
Publicado: (1994)

Diagnostic value of sialyl‐Tn immunocytochemistry in breast cancer presenting with pathological nipple discharge
por: Xu, Feng, et al.
Publicado: (2021)

Evaluation of serum CA125-Tn glycoform in peritoneal dissemination and surgical completeness of high-grade serous ovarian cancer
por: Jin, Xiayu, et al.
Publicado: (2022)

Characterisation of the main PSA glycoforms in aggressive prostate cancer
por: Gratacós-Mulleras, Anna, et al.
Publicado: (2020)

Suppression of Core 1 Gal-Transferase Is Associated with Reduction of TF and Reciprocal Increase of Tn, sialyl-Tn and Core 3 Glycans in Human Colon Cancer Cells
por: Barrow, Hannah, et al.
Publicado: (2013)

A roadmap for translational cancer glycoimmunology at single cell resolution
por: Peixoto, Andreia, et al.
Publicado: (2022)

Combined evaluation of preoperative serum sialyl-Tn antigen and carcinoembryonic antigen levels is prognostic for gastric cancer patients.
por: Takahashi, I., et al.
Publicado: (1994)

Lectin-Based Assay for Glycoform-Specific Detection of α2,6-sialylated Transferrin and Carcinoembryonic Antigen in Tissue and Body Fluid
por: Ito, Hiromi, et al.
Publicado: (2018)

A Rapid LC-MS/MS-PRM Assay for Serologic Quantification of Sialylated O-HPX Glycoforms in Patients with Liver Fibrosis
por: Panigrahi, Aswini, et al.
Publicado: (2022)

A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model
por: Song, Chengcheng, et al.
Publicado: (2017)

Systematic review and meta-analysis of the clinical survival significance of Sialyl-Tn expression in histological tissues from cancer patients
por: Lugo, Roberto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5dgob4dqogegt5013dekf8f62r